Position in AMGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$524,349
+$387,307 QoQ
Shares Held
1,448
+200.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2,146
of 3,140 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $26,373,774 across 11 Drug Manufacturers - General names. AMGN ranks #5 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
90,150 | $17,094,243 | |
| 2 | SNY |
Sanofi
|
115,761 | $4,938,364 | |
| 3 | NVO |
Novo Nordisk A S
|
47,719 | $2,287,648 | |
| 4 | GSK |
GSK plc
|
15,941 | $835,627 | |
| 5 | AMGN |
Amgen Inc
This page
|
1,448 | $524,349 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,941 | $245,225 | |
| 7 | PFE |
Pfizer Inc
|
7,242 | $174,387 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
2,302 | $132,641 |
All Filings in AMGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $524,349 | 1,448 | Shares | Defined | 2026-08-12 | |
| 2024-03-31 | $137,042 | 482 | Shares | Defined | 2024-05-09 | |
| 2023-09-30 | $537 | 2 | Shares | Defined | 2023-11-13 | |
| 2022-09-30 | $9,692 | 43 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||